Galenica AG
SIX:GALE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galenica AG
SIX:GALE
|
CH |
Intrinsic Value
The intrinsic value of Galenica AG (GALE) under the Base Case is 99.9 CHF per share.
Compared with the current market price of 87.8 CHF, the stock appears
Undervalued by 12% .
The intrinsic value is calculated using the DCF method. The model assumes operating margin rises from 5.5% last year to 6.5% by 2031, higher than in any of the last six years. If operating margin stayed at its five-year average of 5.2%, the estimate would be about CHf72.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Galenica Does
Galenica AG is a Swiss healthcare company focused on moving medicines and health products to the people and businesses that need them. It runs a large pharmacy network, distributes prescription drugs and over-the-counter products, and supplies medicines, medical goods, and related services to pharmacies, doctors, hospitals, and care institutions in Switzerland.
- Headquarters
- Switzerland CH
- Employees
- 6 577
- IPO date
- Apr 7, 2017
Latest Earnings Call
- Stock, next trading day
- −1.9%
Earnings Waterfall
Galenica AG
The intrinsic value for Galenica AG (GALE) under the Base Case is 99.9 CHF.
Compared with the current market price of 87.8 CHF, the stock appears Undervalued by 12% .